Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins

Kerstin Rabausch1, Ellen Bretschneider, Mario Sarbia

  • 1Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum Düsseldorf, Germany.

Circulation Research
|December 14, 2004
PubMed

Insights

Cyclooxygenase-2 (COX-2) inhibitors may increase clot risk. This study reveals COX-2 pathway prostaglandins stimulate thrombomodulin, a key coagulation inhibitor, offering a new explanation for this risk.

Area of Science:

  • Cardiovascular Biology
  • Thrombosis Research
  • Pharmacology

Background:

  • Cyclooxygenase-2 (COX-2) inhibitors are associated with atherothrombosis.
  • The prothrombotic risk of COX-2 inhibitors is often attributed to reduced prostacyclin (PGI2) production.
  • Prostacyclin normally inhibits platelet aggregation.

Purpose of the Study:

  • To investigate the effect of COX-2 pathway prostaglandins on thrombomodulin (TM) expression in human smooth muscle cells.
  • To explore a potential platelet-independent mechanism for the prothrombotic effects of COX-2 inhibitors.

Main Methods:

  • Utilized microarray chip technology to assess TM mRNA levels.
  • Studied the expression of functionally active thrombomodulin in human coronary artery smooth muscle cells.
  • Investigated the role of endogenously formed prostaglandins via the COX-2 pathway.

Main Results:

  • Demonstrated that prostaglandins, generated through the COX-2 pathway, stimulate the expression of functionally active thrombomodulin in human smooth muscle cells.
  • Confirmed previous findings of iloprost-induced upregulation of TM mRNA.

Conclusions:

  • Findings suggest a novel, platelet-independent mechanism contributing to the prothrombotic effects of COX-2 inhibitors.
  • Stimulation of thrombomodulin by COX-2 pathway prostaglandins may counteract their antithrombotic effects, explaining observed risks.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.